重组人生长激素在重症急性胆管炎术后的应用

The clinical effection of Human growth hormone in ACST of post-technique

目的观察重组人生长激素(商品名:安苏萌)在重症急性胆管炎(ACST)术后临床应用效果。方法将152例重症急性胆管炎患者随机分为两组,对照组76例(单纯型30例,休克型46例),治疗组76例(单纯型28例,休克型48例)。对照组术后采用综合疗法,治疗组在综合治疗的基础上加用安苏萌。结果治疗组单纯型痊愈率为100%,休克型病死率2.19%(1/48)。对照组单纯型痊愈率100%,休克型病死率17.3%(8/46),两组休克型病死率差异有显著意义(P<0.05)。治疗组对降低血内毒素、血清总胆红素,提高血清白蛋白、转铁蛋白等明显优于对照组(P<0.05)。结论安苏萌在ACST(休克型)术后临床应用可以明显降低病死率。

Objective To observate the clinical effection of Human growth hormone in ACST of post-technique. Methods To divide 152 pou acute cholangitis into two groups ar random. The first group was contrasted, which had 76 pou（simple form：30 pou ,shock form：46）. The other group was cured,inclouding 28 pou simple form and 48 pou shock form. The first group employed the basic therapeusis of colligation,but the other added Ansumeng. Results Fully recover rate of two group was 100 % in simple form,but the death rate was discrepancy（ 17.3 % than 2.19 % ）. The death rate of shock form in the two groups had notable difference（ P 〈 0.05）. To ameliorate poison in body,serum total bilirubin, albumin and siderophilin in the therapeusis group are better than those in the other group. Conclusion Ansumeng can reduce the death rate in ASCT（shock form） of post-technique.